Shares of Catalyst Pharmaceuticals jumped 2.61% to $3.54 at 16:46 EST on Tuesday, after two successive sessions in a row of losses. NASDAQ Composite is rising 0.28% to $13,072.43, following last session’s downward trend, This seems, up to now, a somewhat positive trend trading session today.

Catalyst Pharmaceuticals’s last close was $3.45, 49.15% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 0.8% for the ongoing quarter and 5.5% for the next. The company’s growth estimates for the current quarter is 12.5% and a drop 20% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a negative 0.87%, a negative 0.46%, and a negative 0.12%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 2.04%, 4.18%, and 4.79%, respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $3.54 at 16:46 EST, way below its 52-week high of $5.28 and way higher than its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is below its 50-day moving average of $3.54 and under its 200-day moving average of $3.65.

LEAVE A REPLY

Please enter your comment!
Please enter your name here